Everolimus Use for Intolerance or Failure of Baseline Immunosuppression in Adult Heart and Lung Transplantation.
CONCLUSIONS Everolimus might be beneficial in heart and lung transplant patients with leukopenia or neutropenia and lead to modest, short-term renal function improvement. Patient selection is crucial because adverse effects frequently lead to everolimus discontinuation.
PMID: 30348935 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Kelsh SE, Girgis R, Dickinson M, McDermott JK Tags: Ann Transplant Source Type: research
More News: Bone Graft | Bronchiolitis | Cardiology | Heart | Heart Transplant | Lung Transplant | Study | Transplant Surgery | Transplants